On August 11, 2022, NHS England and NHS Improvement released an updated National Genomic Test Directory for rare and inherited diseases (version 3.1), which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs.
Two documents within the Directory were updated, specifying tests codes, clinical indications, the technology by which tests are available, and eligibility criteria for patients:
- National Genomic Test Directory for rare and inherited diseases;
- Rare and inherited disease eligibility criteria.
No new codes (test-indication combinations) were introduced. Amendments were made for 14 codes, including target genes, test methods, wording, and others.
See the full details here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).